Cancer Pain Market
Cancer Pain Market - Global Industry Assessment & Forecast
#
Pages:
195
Base Year:
2023
Jun - 2024
Format:
Report Code:
VMR-2505
Segments Covered
By
Drug Type Opioids, Non-Opioids, Nerve Blockers
-
By
Disease Indication Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Other Disease Indications
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 7.39 Billion |
 Revenue 2032:
|
USD 11.86 Billion |
 Revenue CAGR
(2024 - 2032): |
5.4% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Cancer Pain Market Segment Analysis
- Cancer Pain Drug Type Outlook (Revenue, USD Million, 2018 - 2030)
- Opioids
- Non-Opioids
- Nerve Blockers
- Cancer Pain Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
-
North America Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- U.S.
- U.S. Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- U.S. Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- U.S. Cancer Pain Market, by Drug Type
- Canada
- Canada Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Canada Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Canada Cancer Pain Market, by Drug Type
-
Mexico
- Mexico Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Mexico Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Mexico Cancer Pain Market, by Drug Type
-
North America Cancer Pain Market, by Drug Type
- Europe
-
Europe Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
-
Europe Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- U. K.
- U.K. Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- U.K. Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- U.K. Cancer Pain Market, by Drug Type
- France
- France Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- France Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- France Cancer Pain Market, by Drug Type
-
Germany
- Germany Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Germany Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Germany Cancer Pain Market, by Drug Type
-
Italy
- Italy Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Italy Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Italy Cancer Pain Market, by Drug Type
-
Spain
- Spain Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Spain Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Spain Cancer Pain Market, by Drug Type
-
Rest of Europe
- Rest of Europe Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Rest of Europe Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Rest of Europe Cancer Pain Market, by Drug Type
-
Europe Cancer Pain Market, by Drug Type
- Asia Pacific
-
Asia Pacific Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
-
Asia Pacific Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- China
- China Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- China Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- China Cancer Pain Market, by Drug Type
- Japan
- Japan Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Japan Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Japan Cancer Pain Market, by Drug Type
-
Germany
- Germany Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Germany Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Germany Cancer Pain Market, by Drug Type
-
India
- India Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- India Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- India Cancer Pain Market, by Drug Type
-
South Korea
- South Korea Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- South Korea Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- South Korea Cancer Pain Market, by Drug Type
-
South East Asia
- South East Asia Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- South East Asia Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- South East Asia Cancer Pain Market, by Drug Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Rest of Asia Pacific Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Rest of Asia Pacific Cancer Pain Market, by Drug Type
-
Asia Pacific Cancer Pain Market, by Drug Type
- Latin America
-
Latin America Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
-
Latin America Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Brazil
- Brazil Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Brazil Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Brazil Cancer Pain Market, by Drug Type
- Argentina
- Argentina Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Argentina Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Argentina Cancer Pain Market, by Drug Type
-
Rest of Latin America
- Rest of Latin America Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Rest of Latin America Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Rest of Latin America Cancer Pain Market, by Drug Type
-
Latin America Cancer Pain Market, by Drug Type
- Middle East & Africa
-
Middle East & Africa Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
-
Middle East & Africa Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- GCC Countries
- GCC Countries Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- GCC Countries Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- GCC Countries Cancer Pain Market, by Drug Type
- South Africa
- South Africa Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- South Africa Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- South Africa Cancer Pain Market, by Drug Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Cancer Pain Market, by Drug Type
- Opioids
- Non-Opioids
- Nerve Blockers
- Rest of Middle East & Africa Cancer Pain Market, by Disease Indication
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Other Disease Indications
- Rest of Middle East & Africa Cancer Pain Market, by Drug Type
-
Middle East & Africa Cancer Pain Market, by Drug Type
- North America
Vantage Market
Research | 25-Jun-2024
FAQ
Frequently Asked Question
What is the global demand for Cancer Pain in terms of revenue?
-
The global Cancer Pain valued at USD 7.39 Billion in 2023 and is expected to reach USD 11.86 Billion in 2032 growing at a CAGR of 5.4%.
Which are the prominent players in the market?
-
The prominent players in the market are Teva Pharmaceutical Industries Ltd. (Israel), Orexo AB (Sweden), Aoxing Pharmaceutical Company Inc. (U.S.), Grünenthal Pharma GmbH & Co. KG (Germany), BioDelivery Sciences International Inc. (U.S.), Daiichi Sankyo Co. Ltd. (Japan), CK Life Sciences (Wex Pharmaceuticals) (Hong Kong), Mundipharma International Ltd. (UK), Hisamitsu Pharmaceutical Co.Inc. (Japan), Pfizer Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 5.4% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cancer Pain include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cancer Pain in 2023.
